Balance Sheet Coloplast A/S

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 08:58:49 2026-04-17 am EDT			5-day change	1st Jan Change
442.60 ^DKK	+2.12%		+3.01%	-19.22%

Apr. 16	Citigroup cuts Coloplast price target to DKK 473 (590), reiterates Neutral - BN	FW
Apr. 07	Goldman Sachs Downgrades Coloplast to Sell Rating, Cuts PT	MT

b750bf6fc.iNjlMB9Im014O97wHk2N8ZDZ-hraxsRrgeTar7tN2Pc.xqvQWHl61jovDuyBUgPst_i7nFyj84YpuK2LwIo8l73wrNByTwzqAxJKsQ

Published financial data: COLOPLAST A/S

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	19.43B	22.58B	24.5B	27.03B	27.87B
Total Revenues	19.43B	22.58B	24.5B	27.03B	27.87B
Cost of Goods Sold, Total	6.11B	7.05B	8.17B	8.76B	8.93B
Gross Profit	13.31B	15.53B	16.33B	18.27B	18.94B
Selling General & Admin Expenses, Total	6.25B	7.8B	8.63B	10.07B	10.42B
Stock-Based Compensation (IS)	2M	-2M	-1M	-	-2M
R&D Expenses	755M	866M	872M	913M	946M
Other Operating Expenses	-28M	-56M	-25M	-22M	-140M
Other Operating Expenses, Total	6.98B	8.61B	9.48B	10.96B	11.22B
Operating Income	6.34B	6.92B	6.85B	7.31B	7.72B
Interest Expense, Total	-25M	-172M	-638M	-795M	-753M
Interest And Investment Income	11M	12M	111M	155M	102M
Net Interest Expenses	-14M	-160M	-527M	-640M	-651M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	114M	-134M	-178M	-218M	-231M
Other Non Operating Income (Expenses)	-31M	-39M	-78M	-85M	-118M
EBT, Excl. Unusual Items	6.41B	6.59B	6.07B	6.37B	6.72B
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-171M	-118M	-89M	-78M
Gain (Loss) On Sale Of Assets	16M	-7M	-3M	-23M	-49M
Legal Settlements	-200M	-300M	-200M	-	-
Other Unusual Items	11M	19M	280M	141M	-437M
EBT, Incl. Unusual Items	6.23B	6.13B	6.02B	6.4B	6.16B
Income Tax Expense	1.41B	1.42B	1.24B	1.34B	2.52B
Earnings From Continuing Operations	4.82B	4.71B	4.78B	5.05B	3.64B
Net Income to Company	4.82B	4.71B	4.78B	5.05B	3.64B
Net Income - (IS)	4.82B	4.71B	4.78B	5.05B	3.64B
Net Income to Common Incl Extra Items	4.82B	4.71B	4.78B	5.05B	3.64B
Net Income to Common Excl. Extra Items	4.82B	4.71B	4.78B	5.05B	3.64B
Per Share Items
Net EPS - Basic	22.67	22.15	22.21	22.46	16.13
Basic EPS - Continuing Operations	22.67	22.15	22.21	22.46	16.13
Basic Weighted Average Shares Outstanding	213M	212M	215M	225M	225M
Net EPS - Diluted	22.63	22.11	22.2	22.46	16.13
Diluted EPS - Continuing Operations	22.63	22.11	22.2	22.46	16.13
Diluted Weighted Average Shares Outstanding	213M	213M	216M	225M	225M
Normalized Basic EPS	18.81	19.37	17.6	17.69	18.64
Normalized Diluted EPS	18.78	19.34	17.59	17.69	18.64
Dividend Per Share	19	20	21	22	23
Payout Ratio	79.38	85.87	88.79	93.43	136.36
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	6.88B	7.54B	7.57B	8.19B	8.63B
EBITA	6.42B	7.11B	7.09B	7.64B	8.06B
EBIT	6.34B	6.92B	6.85B	7.31B	7.72B
EBITDAR	6.92B	7.6B	7.64B	8.25B	8.7B
Effective Tax Rate - (Ratio)	22.59	23.19	20.61	21	40.95
Total Current Taxes	1.2B	1.53B	4.61B	675M	2.12B
Total Deferred Taxes	216M	-98M	-3.34B	676M	415M
Normalized Net Income	4B	4.12B	3.79B	3.98B	4.2B
Interest Capitalized	-	-	-	-	8M
Interest on Long-Term Debt	12M	132M	469M	469M	332M
Non-Cash Pension Expense	3M	2M	4M	5M	4M
Supplemental Operating Expense Items
Selling and Marketing Expenses	5.48B	6.8B	7.52B	8.82B	9.15B
General and Administrative Expenses	762M	1B	1.12B	1.24B	1.27B
Research And Development Expense From Footnotes	755M	866M	872M	913M	946M
Net Rental Expense, Total	41M	55M	67M	63M	73M
Imputed Operating Lease Interest Expense	3.62M	7.04M	17.87M	18.99M	19.63M
Imputed Operating Lease Depreciation	37.38M	47.96M	49.13M	44.01M	53.37M
Stock-Based Comp., Other (Total)	53M	49M	57M	-	-2M
Total Stock-Based Compensation	53M	49M	57M	-	-2M

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	448M	414M	911M	788M	947M
Short Term Investments	226M	219M	-	-	-
Total Cash And Short Term Investments	674M	633M	911M	788M	947M
Accounts Receivable, Total	3.21B	3.94B	4.32B	4.68B	4.66B
Other Receivables	508M	719M	805M	875M	518M
Total Receivables	3.72B	4.66B	5.12B	5.55B	5.18B
Inventory	2.43B	3.19B	3.52B	3.67B	3.92B
Prepaid Expenses	172M	293M	384M	434M	411M
Restricted Cash	-	-	-	-	-
Total Current Assets	6.99B	8.77B	9.94B	10.44B	10.45B
Gross Property Plant And Equipment	9.48B	10.29B	11.1B	11.97B	12.5B
Accumulated Depreciation	-5.89B	-6.15B	-6.36B	-6.7B	-7.06B
Net Property Plant And Equipment	3.58B	4.13B	4.74B	5.27B	5.43B
Long-term Investments	41M	51M	65M	74M	90M
Goodwill	2.03B	11.81B	19.97B	19.38B	19.33B
Other Intangibles, Total	1.54B	8.3B	11.06B	10.72B	10.37B
Deferred Tax Assets Long-Term	743M	674M	884M	624M	587M
Other Long-Term Assets, Total	912M	1.22B	1.5B	1.56B	2.11B
Total Assets	15.84B	34.96B	48.16B	48.07B	48.37B
Liabilities
Accounts Payable, Total	1.04B	1.24B	1.29B	1.52B	1.32B
Accrued Expenses, Total	15M	6M	7M	7M	8M
Current Portion of Long-Term Debt	2.16B	1.64B	7.12B	5.08B	2.33B
Current Portion of Leases	177M	209M	230M	253M	262M
Current Income Taxes Payable	928M	1.34B	4.23B	866M	149M
Unearned Revenue Current, Total	8M	2M	1M	1M	1M
Other Current Liabilities	1.99B	2.89B	3.44B	2.47B	2.43B
Total Current Liabilities	6.31B	7.34B	16.31B	10.2B	6.5B
Long-Term Debt	-	16.36B	11.56B	16.56B	19.35B
Long-Term Leases	449M	496M	664M	734M	696M
Unearned Revenue Non Current	2M	7M	6M	7M	6M
Pension & Other Post Retirement Benefits	181M	115M	124M	126M	111M
Deferred Tax Liability Non Current	671M	2.08B	2.12B	2.48B	3.04B
Other Non Current Liabilities	56M	274M	75M	22M	2.53B
Total Liabilities	7.67B	26.66B	30.86B	30.13B	32.24B
Common Stock, Total	216M	216M	228M	228M	228M
Retained Earnings	8.38B	8.57B	18.23B	19.22B	17.68B
Comprehensive Income and Other	-433M	-495M	-1.16B	-1.51B	-1.78B
Total Common Equity	8.17B	8.29B	17.3B	17.94B	16.12B
Total Equity	8.17B	8.29B	17.3B	17.94B	16.12B
Total Liabilities And Equity	15.84B	34.96B	48.16B	48.07B	48.37B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	213M	212M	225M	225M	225M
ECS Total Common Shares Outstanding	213M	212M	225M	225M	225M
Book Value / Share	38.38	39.06	77	79.69	71.54
Tangible Book Value	4.6B	-11.82B	-13.73B	-12.15B	-13.58B
Tangible Book Value Per Share	21.62	-55.66	-61.12	-53.97	-60.24
Total Debt	2.79B	18.71B	19.57B	22.63B	22.64B
Net Debt	2.11B	18.08B	18.66B	21.84B	21.69B
Debt Equivalent of Unfunded Proj. Benefit Obligation	196M	121M	131M	133M	119M
Debt Equivalent Oper. Leases	328M	440M	536M	504M	584M
Equity Method Investments, Total	41M	51M	65M	74M	90M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	453M	621M	796M	808M	833M
Inventories - Work In Process, Total	580M	722M	755M	797M	886M
Inventories - Finished Goods, Total	1.4B	1.84B	1.97B	2.07B	2.2B
Land - (BS)	2.75B	3.17B	3.48B	3.63B	3.74B
Machinery, Total	6.13B	6.44B	6.78B	7.42B	7.87B
Full Time Employees	12.73K	14.57K	15.69K	16.64K	16.74K
Accumulated Allowance for Doubtful Accounts (Supple)	139M	108M	110M	163M	187M

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	4.82B	4.71B	4.78B	5.05B	3.64B
Depreciation & Amortization - CF	663M	670M	735M	839M	863M
Amortization of Goodwill and Intangible Assets - (CF)	82M	190M	245M	330M	334M
Depreciation & Amortization, Total	745M	860M	980M	1.17B	1.2B
Amortization of Deferred Charges, Total - (CF)	47M	70M	89M	121M	256M
(Gain) Loss From Sale Of Asset	4M	7M	3M	23M	49M
Other Operating Activities, Total	-256M	305M	-736M	-2.57B	2.29B
Change In Accounts Receivable	-235M	-351M	-392M	-506M	-36M
Change In Inventories	-161M	-540M	-474M	-290M	-441M
Change In Accounts Payable	224M	337M	-38M	-81M	-199M
Change in Other Net Operating Assets	97M	-295M	11M	-155M	-109M
Cash from Operations	5.29B	5.1B	4.23B	2.77B	6.64B
Capital Expenditure	-919M	-927M	-1.02B	-1.17B	-1.31B
Sale of Property, Plant, and Equipment	36M	11M	8M	15M	5M
Cash Acquisitions	-97M	-10.63B	-7.92B	-	-
Divestitures	-	-	-	8M	192M
Sale (Purchase) of Intangible assets	-1.05B	-208M	-221M	-180M	-121M
Investment in Marketable and Equity Securities, Total	16M	-2M	199M	-13M	-21M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-2.01B	-11.76B	-8.96B	-1.34B	-1.25B
Short Term Debt Issued, Total	1.05B	-	-	-	-
Long-Term Debt Issued, Total	-	16.37B	622M	7.82B	2.78B
Total Debt Issued	1.05B	16.37B	622M	7.82B	2.78B
Short Term Debt Repaid, Total	-	-5.4B	-	-	-
Long-Term Debt Repaid, Total	-202M	-239M	-244M	-5.12B	-3.04B
Total Debt Repaid	-202M	-5.64B	-244M	-5.12B	-3.04B
Issuance of Common Stock	306M	-	9.13B	500M	27M
Repurchase of Common Stock	-500M	-500M	-	-	-
Common Dividends Paid	-3.83B	-4.04B	-4.25B	-4.72B	-4.96B
Common & Preferred Stock Dividends Paid	-3.83B	-4.04B	-4.25B	-4.72B	-4.96B
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-	402M	-	-	-
Cash from Financing	-3.18B	6.59B	5.26B	-1.52B	-5.19B
Foreign Exchange Rate Adjustments	-	-	-	-31M	-48M
Miscellaneous Cash Flow Adjustments	22M	35M	-37M	-4M	-
Net Change in Cash	125M	-34M	497M	-123M	159M
Supplemental Items
Cash Interest Paid	81M	378M	809M	844M	825M
Cash Income Tax Paid (Refund)	1.5B	1.12B	1.73B	3.96B	571M
Levered Free Cash Flow	2.72B	3.75B	6.36B	-715M	3.58B
Unlevered Free Cash Flow	2.74B	3.86B	6.76B	-218M	4.05B
Change In Net Working Capital	101M	313M	-2.6B	4.73B	801M
Net Debt Issued / Repaid	848M	10.73B	378M	2.7B	-256M

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	27	17.03	10	9.49	10.01
Return on Total Capital	39.4	22.79	13.4	11.8	12.17
Return On Equity %	61.96	57.18	37.38	28.67	21.35
Return on Common Equity	61.96	57.18	37.38	28.67	21.35
Margin Analysis
Gross Profit Margin %	68.53	68.78	66.64	67.59	67.97
SG&A Margin	32.16	34.55	35.24	37.25	37.38
EBITDA Margin %	35.4	33.41	30.89	30.3	30.96
EBITA Margin %	33.04	31.48	28.96	28.26	28.9
EBIT Margin %	32.62	30.64	27.96	27.04	27.7
Income From Continuing Operations Margin %	24.84	20.84	19.52	18.69	13.04
Net Income Margin %	24.84	20.84	19.52	18.69	13.04
Net Avail. For Common Margin %	24.84	20.84	19.52	18.69	13.04
Normalized Net Income Margin	20.61	18.23	15.47	14.72	15.07
Levered Free Cash Flow Margin	14.02	16.6	25.97	-2.64	12.84
Unlevered Free Cash Flow Margin	14.1	17.08	27.6	-0.81	14.52
Asset Turnover
Asset Turnover	1.32	0.89	0.57	0.56	0.58
Fixed Assets Turnover	5.76	5.85	5.52	5.4	5.21
Receivables Turnover (Average Receivables)	6.32	6.31	5.94	6.01	5.97
Inventory Turnover (Average Inventory)	2.63	2.51	2.44	2.44	2.35
Short Term Liquidity
Current Ratio	1.11	1.2	0.61	1.02	1.61
Quick Ratio	0.7	0.72	0.37	0.62	0.94
Operating Cash Flow to Current Liabilities	0.84	0.7	0.26	0.27	1.02
Days Sales Outstanding (Average Receivables)	57.74	57.81	61.49	60.86	61.11
Days Outstanding Inventory (Average Inventory)	138.97	145.35	149.83	150.27	155.15
Average Days Payable Outstanding	53.47	53.24	54.4	57.77	56.54
Cash Conversion Cycle (Average Days)	143.24	149.92	156.91	153.36	159.71
Long Term Solvency
Total Debt/Equity	34.11	225.62	113.11	126.12	140.42
Total Debt / Total Capital	25.43	69.29	53.08	55.78	58.41
LT Debt/Equity	5.5	203.27	70.65	96.37	124.36
Long-Term Debt / Total Capital	4.1	62.43	33.15	42.62	51.72
Total Liabilities / Total Assets	48.44	76.28	64.08	62.68	66.67
EBIT / Interest Expense	253.48	40.23	10.74	9.19	10.25
EBITDA / Interest Expense	283.28	45.23	12.27	10.66	11.84
(EBITDA - Capex) / Interest Expense	246.52	39.84	10.67	9.2	10.11
Total Debt / EBITDA	0.39	2.4	2.5	2.67	2.54
Net Debt / EBITDA	0.3	2.32	2.38	2.58	2.43
Total Debt / (EBITDA - Capex)	0.45	2.73	2.87	3.09	2.97
Net Debt / (EBITDA - Capex)	0.34	2.64	2.74	2.99	2.85
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.76	16.23	8.51	10.33	3.12
Gross Profit, 1 Yr. Growth %	5.56	16.65	5.15	11.89	3.7
EBITDA, 1 Yr. Growth %	6.62	9.38	0.32	8.23	5.36
EBITA, 1 Yr. Growth %	7.61	10.41	-0.21	7.68	5.45
EBIT, 1 Yr. Growth %	8.38	8.84	-1.01	6.72	5.64
Earnings From Cont. Operations, 1 Yr. Growth %	14.96	-2.47	1.64	5.62	-28.03
Net Income, 1 Yr. Growth %	14.96	-2.47	1.64	5.62	-28.03
Normalized Net Income, 1 Yr. Growth %	17.43	2.49	-7.9	4.95	5.58
Diluted EPS Before Extra, 1 Yr. Growth %	15.05	-2.3	0.41	1.17	-28.18
Accounts Receivable, 1 Yr. Growth %	9.48	22.66	9.52	8.34	-0.36
Inventory, 1 Yr. Growth %	9.03	31.26	10.51	4.26	6.73
Net Property, Plant and Equip., 1 Yr. Growth %	13.35	15.32	14.56	11.31	3.03
Total Assets, 1 Yr. Growth %	17.35	120.67	28.61	-0.18	0.61
Tangible Book Value, 1 Yr. Growth %	-10.1	-356.84	-4.03	-11.51	11.72
Common Equity, 1 Yr. Growth %	10.29	1.52	108.62	3.72	-10.14
Cash From Operations, 1 Yr. Growth %	11.16	-3.61	-17.12	-34.55	140.24
Capital Expenditures, 1 Yr. Growth %	8.63	0.87	10.03	14.31	12.01
Levered Free Cash Flow, 1 Yr. Growth %	-14.44	37.01	69.77	-111.34	-600.59
Unlevered Free Cash Flow, 1 Yr. Growth %	-14.45	40.14	75.38	-103.25	-1.96K
Dividend Per Share, 1 Yr. Growth %	5.56	5.26	5	4.76	4.55
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.06	10.34	12.3	9.41	6.66
Gross Profit, 2 Yr. CAGR %	4.48	10.96	10.75	8.46	7.72
EBITDA, 2 Yr. CAGR %	5.37	8.15	4.75	4.2	6.79
EBITA, 2 Yr. CAGR %	6.18	9.17	4.96	3.66	6.56
EBIT, 2 Yr. CAGR %	6.61	8.78	3.8	2.78	6.18
Earnings From Cont. Operations, 2 Yr. CAGR %	11.62	5.89	-0.44	3.61	-12.81
Net Income, 2 Yr. CAGR %	11.62	5.89	-0.44	3.61	-12.81
Normalized Net Income, 2 Yr. CAGR %	8.69	9.88	-2.84	-1.68	5.26
Diluted EPS Before Extra, 2 Yr. CAGR %	11.57	6.02	-0.95	0.79	-14.76
Accounts Receivable, 2 Yr. CAGR %	0.93	15.88	15.91	8.93	3.9
Inventory, 2 Yr. CAGR %	12.07	19.63	20.44	7.34	5.49
Net Property, Plant and Equip., 2 Yr. CAGR %	12.38	14.33	14.98	12.92	7.09
Total Assets, 2 Yr. CAGR %	11.54	60.92	74.36	13.3	0.22
Tangible Book Value, 2 Yr. CAGR %	1.56	51.95	72.75	-7.84	-0.57
Common Equity, 2 Yr. CAGR %	8.7	5.81	45.53	47.1	-3.46
Cash From Operations, 2 Yr. CAGR %	10.19	3.51	-10.62	-26.35	25.4
Capital Expenditures, 2 Yr. CAGR %	22.04	4.68	5.35	12.15	13.15
Levered Free Cash Flow, 2 Yr. CAGR %	-7.93	8.52	52.51	-56.33	-24.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	-7.72	9.74	56.77	-76.23	-22.29
Dividend Per Share, 2 Yr. CAGR %	25.83	5.41	5.13	4.88	4.65
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.7	7.97	9.73	11.64	7.27
Gross Profit, 3 Yr. CAGR %	6.2	8.39	8.99	11.13	6.85
EBITDA, 3 Yr. CAGR %	6.27	6.79	5.47	5.9	4.59
EBITA, 3 Yr. CAGR %	6.85	7.68	5.95	5.86	4.25
EBIT, 3 Yr. CAGR %	7.23	7.46	5.41	4.76	3.72
Earnings From Cont. Operations, 3 Yr. CAGR %	7.86	6.71	4.45	1.54	-8.24
Net Income, 3 Yr. CAGR %	7.86	6.71	4.45	1.54	-8.24
Normalized Net Income, 3 Yr. CAGR %	8.36	6.69	3.6	-0.31	0.68
Diluted EPS Before Extra, 3 Yr. CAGR %	7.73	6.74	4.12	-0.25	-9.98
Accounts Receivable, 3 Yr. CAGR %	3.74	7.71	13.72	13.33	5.74
Inventory, 3 Yr. CAGR %	12.07	18.14	16.51	14.78	7.13
Net Property, Plant and Equip., 3 Yr. CAGR %	7.33	13.35	14.43	13.74	9.52
Total Assets, 3 Yr. CAGR %	10.41	40.03	52.8	44.78	8.9
Tangible Book Value, 3 Yr. CAGR %	5.23	38.36	38.95	38.22	-1.74
Common Equity, 3 Yr. CAGR %	8.37	6.25	32.68	29.99	24.81
Cash From Operations, 3 Yr. CAGR %	6.65	5.38	-3.88	-19.44	9.23
Capital Expenditures, 3 Yr. CAGR %	14.26	14.53	6.43	8.26	12.1
Levered Free Cash Flow, 3 Yr. CAGR %	-4.74	5.28	25.98	-36.07	-1.53
Unlevered Free Cash Flow, 3 Yr. CAGR %	-4.63	6.23	28.3	-57.06	1.64
Dividend Per Share, 3 Yr. CAGR %	19.98	18.56	5.27	5.01	4.77
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.76	7.77	8.29	8.54	8.49
Gross Profit, 5 Yr. CAGR %	5.82	7.95	7.99	8.42	8.48
EBITDA, 5 Yr. CAGR %	5.15	6.04	5.72	5.75	6
EBITA, 5 Yr. CAGR %	5.3	6.54	6.16	6.05	6.19
EBIT, 5 Yr. CAGR %	5.51	6.52	5.91	5.56	5.72
Earnings From Cont. Operations, 5 Yr. CAGR %	8.95	4.39	4.46	5.46	-2.83
Net Income, 5 Yr. CAGR %	8.95	4.39	4.46	5.46	-2.83
Normalized Net Income, 5 Yr. CAGR %	5.79	5.79	3.8	3.26	4.26
Diluted EPS Before Extra, 5 Yr. CAGR %	8.89	4.35	4.17	4.32	-3.89
Accounts Receivable, 5 Yr. CAGR %	3.7	6.39	8.44	8.2	9.69
Inventory, 5 Yr. CAGR %	9.85	13.5	15.35	13.69	11.97
Net Property, Plant and Equip., 5 Yr. CAGR %	7.4	8.97	10.32	13.19	11.44
Total Assets, 5 Yr. CAGR %	7.55	23.74	32.55	30.44	29.08
Tangible Book Value, 5 Yr. CAGR %	4.51	26.28	28.31	22.19	21.54
Common Equity, 5 Yr. CAGR %	10.02	6.86	21.93	21.02	16.83
Cash From Operations, 5 Yr. CAGR %	11.8	9.42	-0.63	-8.69	6.9
Capital Expenditures, 5 Yr. CAGR %	7.95	7	10.61	13.58	9.07
Levered Free Cash Flow, 5 Yr. CAGR %	-0.38	17.84	15.1	-25.96	2.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.31	18.4	16.45	-41.63	4.81
Dividend Per Share, 5 Yr. CAGR %	16.12	13.75	13.81	12.89	5.02